Decoding the ban on irrational fixed-dose combination drugs in India
In September this year, the Government of India banned the manufacture, sale and distribution of 328 Fixed-Dose Combination drugs (FDCs) after a protracted legal battle with manufacturers. The ban followed a report by a Supreme Court-mandated experts’ panel that not only was there no therapeutic justification for the ingredients in these drugs, but they can in fact pose health risks. This paper argues that the move against “irrational” and